Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma and Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00085410
What this trial is testing

Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder

Who this might be right for
Adenocarcinoma of the Extrahepatic Bile DuctAdenocarcinoma of the GallbladderAdvanced Adult Primary Liver Cancer+7 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)WithdrawnNCT04947371
What this trial is testing

Adjuvant Therapy With Anlotinib for HCC

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital
Large-scale testing (Phase 3)WithdrawnNCT04465734
What this trial is testing

A Clinical Study to Compare the Efficacy and Safety of HLX10 in Combination With HLX04 Versus Sorafenib as the First-line Treatment in Patients With Locally Advanced or Metastatic HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
Shanghai Henlius Biotech
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Not applicableLooking for participantsNCT07469319
What this trial is testing

Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis

Who this might be right for
Hepatocellular Carcinoma (HCC)Cirrhosis
University of Aarhus 617
Not applicableStudy completedNCT05681234
What this trial is testing

Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma

Who this might be right for
Liver Carcinoma
Affiliated Hospital of Jiangnan University 30
Not applicableEnded earlyNCT00503867
What this trial is testing

SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma

Who this might be right for
Carcinoma, HepatocellularHepatoma
Sirtex Medical 10
Not applicableUnknownNCT03066557
What this trial is testing

Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Jiangsu Cancer Institute & Hospital 80
Not applicableStudy completedNCT00950144
What this trial is testing

Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver Cancer

Who this might be right for
Colorectal CancerDepressionFatigue+3 more
City of Hope Medical Center 123
Not applicableStudy completedNCT03518632
What this trial is testing

Preoperative Physical Activity Intervention in Patients Before Planned Liver Resection for Cancer (APACHE)

Who this might be right for
Primary Liver CancerSecondary Liver CancerLiver Metastases
Célia Turco 8
Not applicableLooking for participantsNCT02838836
What this trial is testing

Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers

Who this might be right for
Non-small Cell Lung CancerEsophageal CancerGastric Cancer+3 more
University of Missouri-Columbia 620
Not applicableStudy completedNCT02010801
What this trial is testing

Evaluation of Tumor Ablation Effects by Irreversible Electroporation for Patients With Malignant Liver Tumors

Who this might be right for
Malignant Liver Tumors
National Taiwan University Hospital 20
Not applicableUnknownNCT03493763
What this trial is testing

Study on Recurrence Monitoring of Hepatocellular Carcinoma With 5-Hydroxymethylcytosine Test

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 300
Not applicableUnknownNCT06178809
What this trial is testing

Clinical Research on Dynamic Monitoring MRD Via Plasma ctDNA After Systemic Therapy of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Singlera Genomics Inc. 475
Not applicableStudy completedNCT05823584
What this trial is testing

Cell-free DNA From Junction of Hepatitis B Virus Integration in HCC Patients for Monitoring Post-resection Recurrence

Who this might be right for
Hepatocellular Carcinoma
TCM Biotech International Corp. 207
Not applicableStudy completedNCT05352204
What this trial is testing

Effect of Tumor Micronecrosis on Postoperative Transcatheter Arterial Chemoembolization in Patients With Hepatocellular Carcinomas

Who this might be right for
Carcinoma, Hepatocellular
Zhejiang University 900
Not applicableLooking for participantsNCT06805552
What this trial is testing

Sarcopenia and Systemic Therapy in HCC

Who this might be right for
HCC - Hepatocellular Carcinoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 270
Early research (Phase 1)Ended earlyNCT04244552
What this trial is testing

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

Who this might be right for
Breast CancerColorectal CancerOvarian Cancer+13 more
Atreca, Inc. 87
Testing effectiveness (Phase 2)Looking for participantsNCT06695026
What this trial is testing

Evaluate the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir (VGCV) and Atezolizumab/Bevacizumab in Subjects With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Rznomics, Inc. 45
Not applicableStudy completedNCT01910909
What this trial is testing

Stereotactic Body Radiotherapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Localized Non-Resectable Adult Hepatocellular Carcinoma
Samsung Medical Center 56
Next Page